Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 516

1.

Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.

Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

ESC Heart Fail. 2019 Jul 3. doi: 10.1002/ehf2.12455. [Epub ahead of print]

PMID:
31268631
2.

Alteration of medical therapy in patients with heart failure relative to change in symptom severity.

Ibrahim NE, Song Y, Cannon CP, Doros G, Russo P, Ponirakis A, Alexanian C, Januzzi JL Jr.

ESC Heart Fail. 2019 Jul 3. doi: 10.1002/ehf2.12480. [Epub ahead of print]

PMID:
31268222
3.

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.

Mueller C, McDonald K, de Boer RA, Maisel A, Cleland JGF, Kozhuharov N, Coats AJS, Metra M, Mebazaa A, Ruschitzka F, Lainscak M, Filippatos G, Seferovic PM, Meijers WC, Bayes-Genis A, Mueller T, Richards M, Januzzi JL Jr; Heart Failure Association of the European Society of Cardiology.

Eur J Heart Fail. 2019 Jun;21(6):715-731. doi: 10.1002/ejhf.1494.

PMID:
31222929
4.

Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction.

McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL Jr, Wasfy JH.

J Am Coll Cardiol. 2019 Jun 25;73(24):3230-3232. doi: 10.1016/j.jacc.2019.04.016. No abstract available.

PMID:
31221266
5.

Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus.

McCarthy CP, Shrestha S, Ibrahim N, van Kimmenade RRJ, Gaggin HK, Mukai R, Magaret C, Barnes G, Rhyne R, Garasic JM, Januzzi JL.

Open Heart. 2019 May 13;6(1):e000955. doi: 10.1136/openhrt-2018-000955. eCollection 2019.

6.

Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.

Aimo A, Januzzi JL Jr, Mueller C, Mirò O, Pascual Figal DA, Jacob J, Herrero-Puente P, Llorens P, Wussler D, Kozhuharov N, Sabti Z, Breidthardt T, Vergaro G, Ripoli A, Prontera C, Saccaro L, Passino C, Emdin M.

Int J Cardiol. 2019 Jun 4. pii: S0167-5273(19)31104-0. doi: 10.1016/j.ijcard.2019.06.005. [Epub ahead of print]

PMID:
31200964
7.

Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome.

Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, A de Boer R, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M.

Eur J Prev Cardiol. 2019 Jun 1:2047487319852809. doi: 10.1177/2047487319852809. [Epub ahead of print]

PMID:
31154828
8.

Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.

Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, Lopez JAG, de Ferranti SD, Plutzky J, Cannon CP, Januzzi JL Jr, Di Carli MF, Nasir K, Bhatt DL, Blankstein R.

J Am Coll Cardiol. 2019 May 21;73(19):2439-2450. doi: 10.1016/j.jacc.2019.02.059.

PMID:
31097165
9.

Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.

Natarajan P, Collier TS, Jin Z, Lyass A, Li Y, Ibrahim NE, Mukai R, McCarthy CP, Massaro JM, D'Agostino RB Sr, Gaggin HK, Bystrom C, Penn MS, Januzzi JL Jr.

J Am Coll Cardiol. 2019 May 7;73(17):2135-2145. doi: 10.1016/j.jacc.2019.01.073.

PMID:
31047001
10.

Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program.

McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL Jr, de Lemos JA, Yancy C, Fonarow GC, Pandey A.

JAMA Netw Open. 2019 Apr 5;2(4):e192987. doi: 10.1001/jamanetworkopen.2019.2987.

11.

Reply: hs-cTnI in Stable Chest Pain.

Januzzi JL Jr, Ginsburg GS, Douglas PS.

J Am Coll Cardiol. 2019 Apr 30;73(16):2121-2122. doi: 10.1016/j.jacc.2019.02.050. No abstract available.

PMID:
31023439
12.

Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction.

Asensio-Lopez MC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Januzzi JL, Bayes-Genis A, Pascual-Figal DA.

J Mol Cell Cardiol. 2019 May;130:216-233. doi: 10.1016/j.yjmcc.2019.04.009. Epub 2019 Apr 15.

PMID:
30998979
13.

Usefulness of a Positive Psychology-Motivational Interviewing Intervention to Promote Positive Affect and Physical Activity After an Acute Coronary Syndrome.

Huffman JC, Feig EH, Millstein RA, Freedman M, Healy BC, Chung WJ, Amonoo HL, Malloy L, Slawsby E, Januzzi JL, Celano CM.

Am J Cardiol. 2019 Jun 15;123(12):1906-1914. doi: 10.1016/j.amjcard.2019.03.023. Epub 2019 Mar 19.

PMID:
30979409
14.

Race/ethnicity and plasma NT-proBNP in black and white individuals: How it matters.

Emdin M, Aimo A, Clerico A, Januzzi JL.

Int J Cardiol. 2019 Jul 1;286:164-165. doi: 10.1016/j.ijcard.2019.03.032. Epub 2019 Mar 22. No abstract available.

PMID:
30948217
15.

Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry.

Jogu HR, Arora S, Vaduganathan M, Qamar A, Pandey A, Chevli PA, Pansuriya TH, Ahmad MI, Dutta A, Sunkara PR, Qureshi W, Vasu S, Upadhya B, Bhatt DL, Januzzi JL Jr, Herrington D.

Clin Cardiol. 2019 Jun;42(6):592-604. doi: 10.1002/clc.23182. Epub 2019 Apr 12.

16.

Requiem for a Heavyweight: Ejection Fraction as a Prognostic Biomarker.

Januzzi JL Jr.

JACC Heart Fail. 2019 Apr;7(4):318-320. doi: 10.1016/j.jchf.2019.02.002. No abstract available.

PMID:
30922508
17.

Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.

Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL Jr, Scirica BM, Butler J, Cannon CP, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 2;73(12):1596-1598. doi: 10.1016/j.jacc.2019.01.029. No abstract available.

PMID:
30922481
18.

Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score.

O'Connor C, Fiuzat M, Mulder H, Coles A, Ahmad T, Ezekowitz JA, Adams KF, Piña IL, Anstrom KJ, Cooper LS, Mark DB, Whellan DJ, Januzzi JL Jr, Leifer ES, Felker GM.

Eur J Heart Fail. 2019 Jun;21(6):770-778. doi: 10.1002/ejhf.1450. Epub 2019 Mar 27.

PMID:
30919549
19.

Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.

Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC Jr, Iyer S, Januzzi JL Jr.

J Am Coll Cardiol. 2019 Mar 26;73(11):1273-1284. doi: 10.1016/j.jacc.2018.12.063.

PMID:
30898202
20.

Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs.

McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL Jr, Wasfy JH.

JAMA Cardiol. 2019 Mar 17. doi: 10.1001/jamacardio.2019.0716. [Epub ahead of print]

PMID:
30879022
21.

Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction.

McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O'Connor M, Olshan DS, Singh A, Vaduganathan M, Januzzi JL Jr, Wasfy JH.

J Am Coll Cardiol. 2019 Apr 23;73(15):2005-2007. doi: 10.1016/j.jacc.2019.01.032. Epub 2019 Mar 4. No abstract available.

PMID:
30846342
22.

Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes.

McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG, Rivero JM, Vaduganathan M, Januzzi JL Jr, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 23;73(15):2007-2009. doi: 10.1016/j.jacc.2019.01.031. Epub 2019 Mar 4. No abstract available.

PMID:
30846340
23.

Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel.

Januzzi JL Jr, Mahler SA, Christenson RH, Rymer J, Newby LK, Body R, Morrow DA, Jaffe AS.

J Am Coll Cardiol. 2019 Mar 12;73(9):1059-1077. doi: 10.1016/j.jacc.2018.12.046. Epub 2019 Feb 21. Review.

PMID:
30798981
24.

Implementation of an Emergency Department High-Sensitivity Troponin Chest Pain Pathway in the United States.

Baugh CW, Scirica BM, Januzzi JL, Morrow DA, Lewandrowski KB, Jarolim P, White BA, Weinfeld MS, Hoffmann U, Nagurney JT.

Crit Pathw Cardiol. 2019 Mar;18(1):1-4. doi: 10.1097/HPC.0000000000000164. No abstract available.

PMID:
30747757
25.

Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain.

Januzzi JL Jr, Suchindran S, Hoffmann U, Patel MR, Ferencik M, Coles A, Tardif JC, Ginsburg GS, Douglas PS; PROMISE Investigators.

J Am Coll Cardiol. 2019 Jan 29;73(3):251-260. doi: 10.1016/j.jacc.2018.10.065.

PMID:
30678753
26.

Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.

Ibrahim NE, McCarthy CP, Shrestha S, Lyass A, Li Y, Gaggin HK, Simon ML, Massaro JM, D'Agostino RB Sr, Garasic JM, van Kimmenade RR, Januzzi JL Jr.

Am Heart J. 2019 Mar;209:36-46. doi: 10.1016/j.ahj.2018.12.001. Epub 2018 Dec 7.

PMID:
30641399
27.

Trivializing an Elevated Troponin: Adding Insult to Injury?

Januzzi JL Jr, McCarthy CP.

J Am Coll Cardiol. 2019 Jan 8;73(1):10-12. doi: 10.1016/j.jacc.2018.10.042. No abstract available.

PMID:
30621938
28.

Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.

Truong QA, Szymonifka J, Januzzi JL, Contractor JH, Deaño RC, Chatterjee NA, Singh JP.

Heart Rhythm. 2019 Jun;16(6):928-935. doi: 10.1016/j.hrthm.2018.12.023. Epub 2018 Dec 24.

PMID:
30590191
29.

A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography.

Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Magaret CA, Rhyne RF, Januzzi JL Jr.

Clin Cardiol. 2019 Feb;42(2):292-298. doi: 10.1002/clc.23143. Epub 2019 Jan 8.

30.

Pulmonary Production of Soluble ST2 in Heart Failure.

Pascual-Figal DA, Pérez-Martínez MT, Asensio-Lopez MC, Sanchez-Más J, García-García ME, Martinez CM, Lencina M, Jara R, Januzzi JL, Lax A.

Circ Heart Fail. 2018 Dec;11(12):e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488.

PMID:
30562096
31.

Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.

Marti CN, Fonarow GC, Anker SD, Yancy C, Vaduganathan M, Greene SJ, Ahmed A, Januzzi JL, Gheorghiade M, Filippatos G, Butler J.

Eur J Heart Fail. 2019 Mar;21(3):286-296. doi: 10.1002/ejhf.1351. Epub 2018 Dec 10. Review.

PMID:
30537163
32.

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.

Das SR, Everett BM, Birtcher KK, Brown JM, Cefalu WT, Januzzi JL Jr, Kalyani RR, Kosiborod M, Magwire ML, Morris PB, Sperling LS.

J Am Coll Cardiol. 2018 Dec 18;72(24):3200-3223. doi: 10.1016/j.jacc.2018.09.020. Epub 2018 Nov 26. No abstract available.

PMID:
30497881
33.

Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study.

Elmariah S, McCarthy C, Ibrahim N, Furman D, Mukai R, Magaret C, Rhyne R, Barnes G, van Kimmenade RRJ, Januzzi JL Jr.

Open Heart. 2018 Nov 1;5(2):e000916. doi: 10.1136/openhrt-2018-000916. eCollection 2018.

34.

Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.

Mark DB, Cowper PA, Anstrom KJ, Sheng S, Daniels MR, Knight JD, Baloch KN, Davidson-Ray L, Fiuzat M, Januzzi JL Jr, Whellan DJ, Piña IL, Ezekowitz JA, Adams KF, Cooper LS, O'Connor CM, Felker GM.

J Am Coll Cardiol. 2018 Nov 27;72(21):2551-2562. doi: 10.1016/j.jacc.2018.08.2184.

PMID:
30466512
35.

Moving the Needle Toward a More Personalized Means of Patient Care.

Gaggin HK, Januzzi JL Jr.

JAMA Cardiol. 2018 Nov 14. doi: 10.1001/jamacardio.2018.3900. [Epub ahead of print] No abstract available.

PMID:
30427978
36.

Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease.

Khan H, Anker SD, Januzzi JL Jr, McGuire DK, Sattar N, Woerle HJ, Butler J.

J Card Fail. 2019 Feb;25(2):78-86. doi: 10.1016/j.cardfail.2018.10.015. Epub 2018 Nov 10.

PMID:
30423457
37.

High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure.

Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, Magnoli M, Anand IS, Cohn JN, Tavazzi L, Tognoni G, Gravning J, Ueland T, Nymo SH, Rocca HB, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Wilson Tang WH, Grodin JL, Passino C, Emdin M.

Int J Cardiol. 2019 Feb 15;277:166-172. doi: 10.1016/j.ijcard.2018.10.079. Epub 2018 Oct 26.

PMID:
30416028
38.

Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.

Vaduganathan M, Sathiyakumar V, Singh A, McCarthy CP, Qamar A, Januzzi JL Jr, Scirica BM, Butler J, Cannon CP, Bhatt DL.

J Am Coll Cardiol. 2018 Dec 25;72(25):3370-3372. doi: 10.1016/j.jacc.2018.08.2202. No abstract available.

PMID:
30409566
39.

A Stitch in Time: Biomarker-Guided Timing of Aortic Valve Replacement for Severe Aortic Stenosis?

Januzzi JL Jr, Elmariah S.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2182-2184. doi: 10.1016/j.jcin.2018.08.018. No abstract available.

PMID:
30409275
40.

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.

Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL Jr.

J Am Coll Cardiol. 2018 Nov 6;72(19):2309-2320. doi: 10.1016/j.jacc.2018.08.2165.

PMID:
30384887
41.

Clinical Profile of Acute Myocardial Infarction Patients Included in the Hospital Readmissions Reduction Program.

Martin LM, Januzzi JL Jr, Thompson RW, Ferris TG, Singh JP, Bhambhani V, Wasfy JH.

J Am Heart Assoc. 2018 Aug 21;7(16):e009339. doi: 10.1161/JAHA.118.009339.

42.

Established and Emerging Roles of Biomarkers in Heart Failure.

Ibrahim NE, Januzzi JL Jr.

Circ Res. 2018 Aug 17;123(5):614-629. doi: 10.1161/CIRCRESAHA.118.312706.

PMID:
30355136
43.

IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.

Januzzi JL Jr, Packer M, Claggett B, Liu J, Shah AM, Zile MR, Pieske B, Voors A, Gandhi PU, Prescott MF, Shi V, Lefkowitz MP, McMurray JJV, Solomon SD.

Circ Heart Fail. 2018 Oct;11(10):e005133. doi: 10.1161/CIRCHEARTFAILURE.118.005133.

PMID:
30354399
44.

A Novel Paradigm for Sacubitril/Valsartan: Beta-Endorphin Elevation as a Contributor to Exercise Tolerance Improvement in Rats With Preexisting Heart Failure Induced by Pressure Overload.

Maslov MY, Foianini S, Orlov MV, Januzzi JL, Lovich MA.

J Card Fail. 2018 Nov;24(11):773-782. doi: 10.1016/j.cardfail.2018.10.006. Epub 2018 Oct 19.

PMID:
30347271
45.

Exercise-induced Changes in Soluble ST2 Concentrations in Marathon Runners.

Aengevaeren VL, VAN Kimmenade RRJ, Hopman MTE, VAN Royen N, Snider JV, Januzzi JL, George KP, Eijsvogels TMH.

Med Sci Sports Exerc. 2019 Mar;51(3):405-410. doi: 10.1249/MSS.0000000000001806.

46.

[Fourth universal definition of myocardial infarction (2018)].

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Alonso Garcia MA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS, Newby LK, Virmani R, Vranckx P, Cutlip D, Gibbons RJ, Smith SC, Atar D, Luepker RV, Robertson RM, Bonow RO, Steg PG, O'Gara PT, Fox KAA.

Kardiol Pol. 2018;76(10):1383-1415. doi: 10.5603/KP.2018.0203. Polish. No abstract available.

47.

Endurance Exercise Training Attenuates Natriuretic Peptide Release During Maximal Effort Exercise: Biochemical Correlates of the "Athlete's Heart".

Shah AB, Zilinski J, Brown MG, Neary JH, Weiner RB, Hutter AM, Apple FS, Picard MH, Januzzi JL, Baggish AL.

J Appl Physiol (1985). 2018 Oct 11. doi: 10.1152/japplphysiol.00293.2018. [Epub ahead of print]

PMID:
30307785
48.

NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure.

Vergaro G, Januzzi JL Jr, Cohen Solal A, Aimo A, Arzilli C, Zyw L, Valleggi A, Giannoni A, Prontera C, Barison A, Poletti R, Gabutti A, Mammini C, Passino C, Emdin M.

Int J Cardiol. 2018 Nov 15;271:324-330. doi: 10.1016/j.ijcard.2018.04.006.

PMID:
30223365
49.

Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study.

Ibrahim NE, Gupta R, Lyass A, Li Y, Shrestha S, McCarthy CP, Gaggin HK, van Kimmenade RRJ, Massaro JM, D'Agostino RB Sr, Januzzi JL Jr.

Clin Chem. 2018 Nov;64(11):1617-1625. doi: 10.1373/clinchem.2017.286385. Epub 2018 Sep 13.

PMID:
30213784
50.

Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction.

Pérez-Martínez MT, Lacunza-Ruiz J, García de Lara J, Noguera-Velasco JA, Lax A, Hernández-Vicente Á, Asensio-López MC, Januzzi JL Jr, Ibañez B, Pascual-Figal DA.

J Am Coll Cardiol. 2018 Sep 18;72(12):1429-1430. doi: 10.1016/j.jacc.2018.06.062. No abstract available.

PMID:
30213338

Supplemental Content

Loading ...
Support Center